Yongjun Guan

1.4k total citations · 1 hit paper
34 papers, 871 citations indexed

About

Yongjun Guan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yongjun Guan has authored 34 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Yongjun Guan's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Yongjun Guan is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Yongjun Guan collaborates with scholars based in China, United States and Ethiopia. Yongjun Guan's co-authors include Weixing Wang, Jian-ying Ma, Wei Song, Qiao Shi, Ning Hu, Xuanzhe Zhang, Xingcheng Xiong, Jiarui Feng, Hanjun Li and Fang Jiang and has published in prestigious journals such as Blood, Diabetes Care and Frontiers in Immunology.

In The Last Decade

Yongjun Guan

32 papers receiving 864 citations

Hit Papers

Clinical Characteristics and Risk Factors for Mortality o... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers

Yongjun Guan
Ibrahim Y. Hachim United Arab Emirates
Derick Okwan‐Duodu United States
Silvia Ottaviani United Kingdom
Shi Jin China
Ibrahim Y. Hachim United Arab Emirates
Yongjun Guan
Citations per year, relative to Yongjun Guan Yongjun Guan (= 1×) peers Ibrahim Y. Hachim

Countries citing papers authored by Yongjun Guan

Since Specialization
Citations

This map shows the geographic impact of Yongjun Guan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongjun Guan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongjun Guan more than expected).

Fields of papers citing papers by Yongjun Guan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongjun Guan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongjun Guan. The network helps show where Yongjun Guan may publish in the future.

Co-authorship network of co-authors of Yongjun Guan

This figure shows the co-authorship network connecting the top 25 collaborators of Yongjun Guan. A scholar is included among the top collaborators of Yongjun Guan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongjun Guan. Yongjun Guan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Lilong, et al.. (2022). Systematic analysis of the role of SLC52A2 in multiple human cancers. Cancer Cell International. 22(1). 8–8. 12 indexed citations
2.
Zhang, Lilong, Tianrui Kuang, Chunlei Li, et al.. (2022). The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors. Frontiers in Pharmacology. 13. 937874–937874. 25 indexed citations
3.
Zhang, Yichao, Zhendong Qiu, Yongjun Guan, et al.. (2022). STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway. Cancer Cell International. 22(1). 4–4. 12 indexed citations
4.
Zhang, Lilong, Chen Chen, Chunlei Li, et al.. (2022). The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors. Frontiers in Immunology. 13. 956533–956533. 31 indexed citations
5.
Kuang, Chunmei, Yinghong Zhu, Yongjun Guan, et al.. (2021). COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion. Cellular Oncology. 44(3). 643–659. 3 indexed citations
6.
Qiu, Zhendong, Wenhong Deng, Yu-pu Hong, et al.. (2021). Biological Behavior and Lipid Metabolism of Colon Cancer Cells are Regulated by a Combination of Sterol Regulatory Element-Binding Protein 1 and ATP Citrate Lyase. OncoTargets and Therapy. Volume 14. 1531–1542. 11 indexed citations
7.
Zhang, Lilong, et al.. (2021). Prognostic Value and Immunological Role of MORF4-Related Gene-Binding Protein in Human Cancers. Frontiers in Cell and Developmental Biology. 9. 703415–703415. 4 indexed citations
8.
Guan, Yongjun, Man Li, Zhendong Qiu, et al.. (2021). Comprehensive analysis of DOK family genes expression, immune characteristics, and drug sensitivity in human tumors. Journal of Advanced Research. 36. 73–87. 12 indexed citations
9.
Zang, Meirong, Jiaojiao Guo, Lanting Liu, et al.. (2020). Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. Oncogenesis. 9(3). 31–31. 11 indexed citations
10.
Guan, Yongjun, et al.. (2019). <p>Development and validation of prognostic nomograms for medullary thyroid cancer</p>. OncoTargets and Therapy. Volume 12. 2299–2309. 2 indexed citations
11.
Guan, Yongjun, Jian-ying Ma, & Wei Song. (2019). Identification of circRNA–miRNA–mRNA regulatory network in gastric cancer by analysis of microarray data. Cancer Cell International. 19(1). 183–183. 77 indexed citations
12.
Xia, Jiliang, Yanjuan He, Bin Meng, et al.. (2019). NEK2 Promotes Bortezomib Resistance through Enhancing Autophagy By Upregulation of Beclin1 in Multiple Myeloma Cells. Blood. 134(Supplement_1). 4332–4332.
13.
Guan, Yongjun, Hongbo Shi, & Tianlin Xiao. (2018). NUAK1 knockdown suppresses prostate cancer cell epithelial-mesenchymal transition, migration, and invasion through microRNA-30b-5p.. PubMed Central. 11(12). 5694–5704. 12 indexed citations
14.
Wu, Qiong, et al.. (2018). Nomograms for estimating survival in patients with liver-only colorectal metastases: A retrospective study. International Journal of Surgery. 60. 1–8. 19 indexed citations
15.
Yi, Hongmei, Hong Yi, Jinfeng Zhu, et al.. (2015). A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy. Tumor Biology. 37(3). 2941–2949. 20 indexed citations
16.
Guan, Rui, et al.. (2013). ZNF403, a Novel Cell Cycle Regulator. ACTA AGRONOMICA SINICA. 40(2). 147–147. 3 indexed citations
17.
Cui, Li, Danjuan Li, Yuanjie Xie, et al.. (2012). Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma. Clinical & Experimental Metastasis. 29(8). 865–877. 35 indexed citations
18.
Tang, Can‐E, Yongjun Guan, Bin Yi, et al.. (2010). Identification of the Amyloid β-Protein Precursor and Cystatin C as Novel Epidermal Growth Factor Receptor Regulated Secretory Proteins in Nasopharyngeal Carcinoma by Proteomics. Journal of Proteome Research. 9(12). 6101–6111. 29 indexed citations
19.
Xiu-sheng, HE, Zhuchu Chen, Fang Tian, et al.. (2003). [Identification of down-regulated expressed sequence tag at chromosome 3p21 in nasopharyngeal carcinoma].. PubMed. 22(1). 1–5. 4 indexed citations
20.
Zhan, Xianquan, Yongjun Guan, Cui Li, et al.. (2002). [Differential proteomic analysis of human lung adenocarcinoma cell line A-549 and of normal cell line HBE].. PubMed. 34(1). 50–6. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026